Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL)...

FDA Recall #D-0649-2024 — Class I — August 1, 2024

Recall #D-0649-2024 Date: August 1, 2024 Classification: Class I Status: Ongoing

Product Description

Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04

Reason for Recall

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Recalling Firm

Baxter Healthcare Corporation — Round Lake, IL

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

44,208 containers

Distribution

Nationwide in the USA

Code Information

Lot # N008235, Exp 8/31/2024

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated